Universe Pharmaceuticals (UPC) Shares Outstanding (2020 - 2025)
Universe Pharmaceuticals (UPC) reported Shares Outstanding (Entity) of $6.1 billion for Q1 2024, up 0.58% on a YoY basis from $6.0 billion in Q2 2023, and up 0.58% sequentially from $6.0 billion in Q1 2023.
Universe Pharmaceuticals (UPC) Shares Outstanding (2020 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 3 years of Shares Outstanding (Entity) data on file, last reported at $6.1 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 455,871.00 |
| Sep 30, 2024 | 13,920.00 |
| Mar 31, 2024 | 6.08 Bn |
| Sep 30, 2023 | 6,042.00 |
| Mar 31, 2023 | 6.04 Bn |
| Sep 30, 2022 | 6,042.00 |
| Mar 31, 2022 | 6.04 Bn |
| Sep 30, 2021 | 5,273.00 |
| Sep 30, 2020 | 4,445.00 |